CLRB Earnings

Quarterly EPS
$-1.68
Q4 2024
$-4.30
Q1 2025
$-3.39
Q2 2025
$-1.41
Q3 2025
$-1.28
Q4 2025
$-1.33
Q1 2026
$-0.57
Q2 2026
$-0.46
Q3 2026
Latest RevenueN/A
Latest Net Income-7974743
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.460-7974743—+67.4%
Q2 2026-$0.570-6930653—+83.2%
Q1 2026-$1.330-5653946—+69.1%
Q4 2025-$1.280-5295221—+23.8%
Q3 2025-$1.410-4443877—+87.4%
Q2 2025-$3.390-5447911—-340.3%
Q1 2025-$4.300-6604029—+84.2%
Q4 2024-$1.680-2355373—+89.3%
Q3 2024-$11.180-14664719——
Q2 2024-$0.770-919371——
Q1 2024-$27.300-26641983——
Q4 2023-$15.700-7881122——
Cellectar Biosciences INC NEW (CLRB) — Earnings